BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30226128)

  • 1. Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program.
    Asundi A; Stanislawski M; Mehta P; Barón AE; Gold H; Mull H; Ho PM; Gupta K; Branch-Elliman W
    Infect Control Hosp Epidemiol; 2018 Sep; 39(9):1030-1036. PubMed ID: 30226128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
    Branch-Elliman W; Ripollone JE; O'Brien WJ; Itani KMF; Schweizer ML; Perencevich E; Strymish J; Gupta K
    PLoS Med; 2017 Jul; 14(7):e1002340. PubMed ID: 28692690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?
    Branch-Elliman W; Stanislawski M; Strymish J; Barón AE; Gupta K; Varosy PD; Gold HS; Ho PM
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1005-11. PubMed ID: 27322021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.
    Asundi A; Stanislawski M; Mehta P; Baron AE; Mull HJ; Ho PM; Zimetbaum PJ; Gupta K; Branch-Elliman W
    Infect Control Hosp Epidemiol; 2019 Aug; 40(8):855-862. PubMed ID: 31159895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events.
    Branch-Elliman W; O'Brien W; Strymish J; Itani K; Wyatt C; Gupta K
    JAMA Surg; 2019 Jul; 154(7):590-598. PubMed ID: 31017647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
    Poeran J; Mazumdar M; Rasul R; Meyer J; Sacks HS; Koll BS; Wallach FR; Moskowitz A; Gelijns AC
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):589-97.e2. PubMed ID: 26545971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
    Courtney PM; Melnic CM; Zimmer Z; Anari J; Lee GC
    Clin Orthop Relat Res; 2015 Jul; 473(7):2197-203. PubMed ID: 25421958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
    Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
    Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
    Bateman BT; Rassen JA; Schneeweiss S; Bykov K; Franklin JM; Gagne JJ; Polinski JM; Liu J; Kulik A; Fischer MA; Choudhry NK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):472-8. PubMed ID: 23541855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis.
    Kirkwood KA; Gulack BC; Iribarne A; Bowdish ME; Greco G; Mayer ML; O'Sullivan K; Gelijns AC; Fumakia N; Ghanta RK; Raiten JM; Lala A; Ladowski JS; Blackstone EH; Parides MK; Moskowitz AJ; Horvath KA
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):670-678.e1. PubMed ID: 29102205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.
    Asundi A; Stanislawski M; Mehta P; Mull HJ; Schweizer ML; Barón AE; Ho PM; Gupta K; Branch-Elliman W
    Sci Rep; 2020 Mar; 10(1):5276. PubMed ID: 32210289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.
    Mull HJ; Stolzmann K; Kalver E; Shin MH; Schweizer ML; Asundi A; Mehta P; Stanislawski M; Branch-Elliman W
    BMC Med Inform Decis Mak; 2020 Jan; 20(1):15. PubMed ID: 32000780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antimicrobial agent pocket irrigation for cardiovascular implantable electronic device infection prophylaxis: Results from an international survey.
    Zheng Q; Di Biase L; Ferrick KJ; Gross JN; Guttenplan NA; Kim SG; Krumerman AK; Palma EC; Fisher JD
    Pacing Clin Electrophysiol; 2018 Oct; 41(10):1298-1306. PubMed ID: 30109698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
    Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
    N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial use and risk for recurrent Clostridium difficile infection.
    Drekonja DM; Amundson WH; Decarolis DD; Kuskowski MA; Lederle FA; Johnson JR
    Am J Med; 2011 Nov; 124(11):1081.e1-7. PubMed ID: 21944159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
    Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative antibiotics and cardiovascular implantable electronic device infection: A cohort study in veterans.
    Alzahrani T; Liappis AP; Baddour LM; Karasik PE
    Pacing Clin Electrophysiol; 2018 Nov; 41(11):1513-1518. PubMed ID: 30221380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections.
    Le KY; Sohail MR; Friedman PA; Uslan DZ; Cha SS; Hayes DL; Wilson WR; Steckelberg JM; Baddour LM;
    Heart Rhythm; 2011 Nov; 8(11):1678-85. PubMed ID: 21699855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Method to Flag Cardiac Implantable Device Infections by Integrating Text Mining With Structured Data in the Veterans Health Administration's Electronic Medical Record.
    Mull HJ; Stolzmann KL; Shin MH; Kalver E; Schweizer ML; Branch-Elliman W
    JAMA Netw Open; 2020 Sep; 3(9):e2012264. PubMed ID: 32955571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.